澳大利亚 - 英文 - Department of Health (Therapeutic Goods Administration)

kl4 pty ltd - ricinus communis, quantity: 12.5 mg/ml (equivalent: ricinus communis, qty 62.5 mg/ml); plumbago europaea, quantity: 12.5 mg/ml (equivalent: plumbago europaea, qty 62.5 mg/ml); zingiber officinale, quantity: 12.5 mg/ml (equivalent: zingiber officinale, qty 62.5 mg/ml); terminalia chebula, quantity: 12.5 mg/ml (equivalent: terminalia chebula, qty 62.5 mg/ml); phyllanthus emblica, quantity: 12.5 mg/ml (equivalent: phyllanthus emblica, qty 62.5 mg/ml); boerhavia diffusa, quantity: 12.5 mg/ml (equivalent: boerhavia diffusa, qty 62.5 mg/ml); moringa oleifera, quantity: 12.5 mg/ml (equivalent: moringa oleifera, qty 62.5 mg/ml) - liquids - excipient ingredients: potable water; sodium benzoate - decrease/reduce/relieve mild rheumatic aches and pains ; decrease/reduce/relieve loss of appetite ; decrease/reduce/relieve flatulence/carminative ; decrease/reduce/relieve abdominal bloating/distention ; antacid/reduces stomach acid ; helps delay stomach (gastric) emptying ; decrease/reduce/relieve muscle pain/ache/soreness

澳大利亚 - 英文 - Department of Health (Therapeutic Goods Administration)

orion laboratories pty ltd t/a perrigo australia - triclosan, quantity: 10 mg/ml - application - excipient ingredients: edetate sodium; methyl hydroxybenzoate; dibasic sodium phosphate; purified water; citric acid; ethanol; sodium lauryl sulfate; fragrance (perfume); glycerol; cocamide dea; coconut oil; diethanolamine - a foaming emolient antiseptic soap for pre-operative washing to cleanse and disinfect the skin.

澳大利亚 - 英文 - APVMA (Australian Pesticides and Veterinary Medicines Authority)

intervet australia pty limited - gonadotrophin-chorionic - unknown - gonadotrophin-chorionic hormone-gonadotrophin active 0.0 - active constituent

澳大利亚 - 英文 - APVMA (Australian Pesticides and Veterinary Medicines Authority)

intervet australia pty limited - gonadotrophin-chorionic - unknown - gonadotrophin-chorionic hormone-gonadotrophin active 0.0 - active constituent

新西兰 - 英文 - Medsafe (Medicines Safety Authority)

orion laboratories (nz) ltd - temozolomide 100mg - capsule - 100 mg - active: temozolomide 100mg excipient: colloidal silicon dioxide gelatin lactose sodium starch glycolate stearic acid tartaric acid titanium dioxide - treatment of: - patients with newly diagnosed glioblastoma multiforme concomitantly with radiotherapy and then as adjuvant treatment - patients with recurrent high grade glioma, such as glioblastoma multiforme or anaplastic astrocytoma

新西兰 - 英文 - Medsafe (Medicines Safety Authority)

orion laboratories (nz) ltd - temozolomide 140mg - capsule - 140 mg - active: temozolomide 140mg excipient: colloidal silicon dioxide gelatin lactose sodium starch glycolate stearic acid tartaric acid titanium dioxide - treatment of: - patients with newly diagnosed glioblastoma multiforme concomitantly with radiotherapy and then as adjuvant treatment - patients with recurrent high grade glioma, such as glioblastoma multiforme or anaplastic astrocytoma

新西兰 - 英文 - Medsafe (Medicines Safety Authority)

orion laboratories (nz) ltd - temozolomide 180mg - capsule - 180 mg - active: temozolomide 180mg excipient: colloidal silicon dioxide gelatin lactose sodium starch glycolate stearic acid tartaric acid titanium dioxide - treatment of: - patients with newly diagnosed glioblastoma multiforme concomitantly with radiotherapy and then as adjuvant treatment - patients with recurrent high grade glioma, such as glioblastoma multiforme or anaplastic astrocytoma

新西兰 - 英文 - Medsafe (Medicines Safety Authority)

orion laboratories (nz) ltd - temozolomide 20mg - capsule - 20 mg - active: temozolomide 20mg excipient: colloidal silicon dioxide gelatin lactose sodium starch glycolate stearic acid tartaric acid titanium dioxide - treatment of: - patients with newly diagnosed glioblastoma multiforme concomitantly with radiotherapy and then as adjuvant treatment - patients with recurrent high grade glioma, such as glioblastoma multiforme or anaplastic astrocytoma

新西兰 - 英文 - Medsafe (Medicines Safety Authority)

orion laboratories (nz) ltd - temozolomide 250mg - capsule - 250 mg - active: temozolomide 250mg excipient: colloidal silicon dioxide gelatin lactose sodium starch glycolate stearic acid tartaric acid titanium dioxide - treatment of: - patients with newly diagnosed glioblastoma multiforme concomitantly with radiotherapy and then as adjuvant treatment - patients with recurrent high grade glioma, such as glioblastoma multiforme or anaplastic astrocytoma

新西兰 - 英文 - Medsafe (Medicines Safety Authority)

orion laboratories (nz) ltd - temozolomide 5mg - capsule - 5 mg - active: temozolomide 5mg excipient: colloidal silicon dioxide gelatin lactose sodium starch glycolate stearic acid tartaric acid tekprint green sb-4020 titanium dioxide - treatment of: - patients with newly diagnosed glioblastoma multiforme concomitantly with radiotherapy and then as adjuvant treatment - patients with recurrent high grade glioma, such as glioblastoma multiforme or anaplastic astrocytoma